Acro Biomedical (ACBM) Income towards Parent Company (2016 - 2025)
Acro Biomedical's quarterly Income towards Parent Company came in at $42526.0 in Q4 2025, up 498.44% year-on-year from $7106.1 in Q4 2024, and up 136.1% quarter-over-quarter from -$117809.0 in Q3 2025.
Acro Biomedical has reported Income towards Parent Company for 10 years, with the latest figure at $42526.0 in Q4 2025.
- For the quarter ending Q4 2025, Income towards Parent Company rose 498.44% year-over-year to $42526.0; the trailing twelve-month figure through Dec 2025 stood at -$101146.0 (down 139.13% YoY), and the FY2025 full-year result was -$101146.0, down 139.13% from the prior year.
- Income towards Parent Company for Q4 2025 stood at $42526.0, up from -$117809.0 in the prior quarter.
- The five-year high for Income towards Parent Company was $42526.0 in Q4 2025, with the low at -$4.0 million in Q3 2022.
- Average Income towards Parent Company over 5 years is -$1.6 million, with a median of -$456248.0 recorded in 2021.
- Year-over-year, Income towards Parent Company tumbled 6503.69% in 2022 and surged 498.44% in 2025.
- Tracing ACBM's Income towards Parent Company over 5 years: stood at -$3.8 million in 2021, then dropped by 2.21% to -$3.9 million in 2022, then soared by 99.54% to -$18240.0 in 2023, then surged by 41.49% to -$10673.0 in 2024, then surged by 498.44% to $42526.0 in 2025.
- The last three Income towards Parent Company figures came in at $42526.0 (Q4 2025), -$117809.0 (Q3 2025), and -$15562.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42,526.00 |
| Sep 30, 2025 | -117,809.00 |
| Jun 30, 2025 | -15,562.00 |
| Mar 31, 2025 | -10,301.00 |
| Dec 31, 2024 | -10,673.00 |
| Sep 30, 2024 | -10,229.00 |
| Jun 30, 2024 | -10,143.00 |
| Mar 31, 2024 | -11,252.00 |
| Dec 31, 2023 | -18,240.00 |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -3.20 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | -3.93 Mn |
| Sep 30, 2022 | -4.01 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -3.93 Mn |
| Dec 31, 2021 | -3.85 Mn |
| Sep 30, 2021 | -2.99 Mn |
| Jun 30, 2021 | -794,687.00 |
| Mar 31, 2021 | -59,494.00 |
| Sep 30, 2020 | -73,099.00 |
| Jun 30, 2020 | -63,699.00 |
| Mar 31, 2020 | 81,116.00 |
| Dec 31, 2019 | -75,873.00 |
| Sep 30, 2019 | -75,157.00 |
| Jun 30, 2019 | -50,824.00 |
| Mar 31, 2019 | -169,750.00 |
| Dec 31, 2018 | -75,016.00 |
| Sep 30, 2018 | 153,672.00 |
| Jun 30, 2018 | 116,309.00 |
| Mar 31, 2018 | 69,452.00 |
| Dec 31, 2017 | 80,227.00 |
| Sep 30, 2017 | 39,495.00 |
| Jun 30, 2017 | -11,887.00 |
| Mar 31, 2017 | -22,443.00 |
| Dec 31, 2016 | -7,413.00 |